Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision tag v3.6.5 has been added, replacing the previous v3.6.4 to indicate the latest software release for the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3, indicating a new build. This is a maintenance/version update and does not reflect changes to the study content or its presentation.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, indicating a version update to the page or its underlying template. It does not appear to modify core study content or participant information.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment label, replacing the previous Intervention / Treatment. The page now also shows the recruitment status as 'No longer looking for participants', indicating that enrollment has ended.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.5.5 is now shown in the page's revision history, replacing the previous Revision: v3.5.4.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates an updated version of the referenced document or page metadata.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.